Generic Injectables Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Injectables Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Small Molecule
1.2.3 Large Molecule
1.3 Market by Application
1.3.1 Global Generic Injectables Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Anesthesia
1.3.4 Anti-Infectives
1.3.5 Parenteral Nutrition
1.3.6 Cardiovascular Diseases
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Generic Injectables Market Perspective (2017-2028)
2.2 Generic Injectables Growth Trends by Region
2.2.1 Generic Injectables Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Generic Injectables Historic Market Size by Region (2017-2022)
2.2.3 Generic Injectables Forecasted Market Size by Region (2023-2028)
2.3 Generic Injectables Market Dynamics
2.3.1 Generic Injectables Industry Trends
2.3.2 Generic Injectables Market Drivers
2.3.3 Generic Injectables Market Challenges
2.3.4 Generic Injectables Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Injectables Players by Revenue
3.1.1 Global Top Generic Injectables Players by Revenue (2017-2022)
3.1.2 Global Generic Injectables Revenue Market Share by Players (2017-2022)
3.2 Global Generic Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Generic Injectables Revenue
3.4 Global Generic Injectables Market Concentration Ratio
3.4.1 Global Generic Injectables Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Injectables Revenue in 2021
3.5 Generic Injectables Key Players Head office and Area Served
3.6 Key Players Generic Injectables Product Solution and Service
3.7 Date of Enter into Generic Injectables Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Injectables Breakdown Data by Type
4.1 Global Generic Injectables Historic Market Size by Type (2017-2022)
4.2 Global Generic Injectables Forecasted Market Size by Type (2023-2028)
5 Generic Injectables Breakdown Data by Application
5.1 Global Generic Injectables Historic Market Size by Application (2017-2022)
5.2 Global Generic Injectables Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Generic Injectables Market Size (2017-2028)
6.2 North America Generic Injectables Market Size by Type
6.2.1 North America Generic Injectables Market Size by Type (2017-2022)
6.2.2 North America Generic Injectables Market Size by Type (2023-2028)
6.2.3 North America Generic Injectables Market Share by Type (2017-2028)
6.3 North America Generic Injectables Market Size by Application
6.3.1 North America Generic Injectables Market Size by Application (2017-2022)
6.3.2 North America Generic Injectables Market Size by Application (2023-2028)
6.3.3 North America Generic Injectables Market Share by Application (2017-2028)
6.4 North America Generic Injectables Market Size by Country
6.4.1 North America Generic Injectables Market Size by Country (2017-2022)
6.4.2 North America Generic Injectables Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Generic Injectables Market Size (2017-2028)
7.2 Europe Generic Injectables Market Size by Type
7.2.1 Europe Generic Injectables Market Size by Type (2017-2022)
7.2.2 Europe Generic Injectables Market Size by Type (2023-2028)
7.2.3 Europe Generic Injectables Market Share by Type (2017-2028)
7.3 Europe Generic Injectables Market Size by Application
7.3.1 Europe Generic Injectables Market Size by Application (2017-2022)
7.3.2 Europe Generic Injectables Market Size by Application (2023-2028)
7.3.3 Europe Generic Injectables Market Share by Application (2017-2028)
7.4 Europe Generic Injectables Market Size by Country
7.4.1 Europe Generic Injectables Market Size by Country (2017-2022)
7.4.2 Europe Generic Injectables Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Generic Injectables Market Size (2017-2028)
8.2 Asia-Pacific Generic Injectables Market Size by Type
8.2.1 Asia-Pacific Generic Injectables Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Generic Injectables Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Generic Injectables Market Share by Type (2017-2028)
8.3 Asia-Pacific Generic Injectables Market Size by Application
8.3.1 Asia-Pacific Generic Injectables Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Generic Injectables Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Generic Injectables Market Share by Application (2017-2028)
8.4 Asia-Pacific Generic Injectables Market Size by Region
8.4.1 Asia-Pacific Generic Injectables Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Generic Injectables Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Generic Injectables Market Size (2017-2028)
9.2 Latin America Generic Injectables Market Size by Type
9.2.1 Latin America Generic Injectables Market Size by Type (2017-2022)
9.2.2 Latin America Generic Injectables Market Size by Type (2023-2028)
9.2.3 Latin America Generic Injectables Market Share by Type (2017-2028)
9.3 Latin America Generic Injectables Market Size by Application
9.3.1 Latin America Generic Injectables Market Size by Application (2017-2022)
9.3.2 Latin America Generic Injectables Market Size by Application (2023-2028)
9.3.3 Latin America Generic Injectables Market Share by Application (2017-2028)
9.4 Latin America Generic Injectables Market Size by Country
9.4.1 Latin America Generic Injectables Market Size by Country (2017-2022)
9.4.2 Latin America Generic Injectables Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Injectables Market Size (2017-2028)
10.2 Middle East & Africa Generic Injectables Market Size by Type
10.2.1 Middle East & Africa Generic Injectables Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Generic Injectables Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Generic Injectables Market Share by Type (2017-2028)
10.3 Middle East & Africa Generic Injectables Market Size by Application
10.3.1 Middle East & Africa Generic Injectables Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Generic Injectables Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Generic Injectables Market Share by Application (2017-2028)
10.4 Middle East & Africa Generic Injectables Market Size by Country
10.4.1 Middle East & Africa Generic Injectables Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Generic Injectables Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Hospira (Pfizer Inc.)
11.1.1 Hospira (Pfizer Inc.) Company Details
11.1.2 Hospira (Pfizer Inc.) Business Overview
11.1.3 Hospira (Pfizer Inc.) Generic Injectables Introduction
11.1.4 Hospira (Pfizer Inc.) Revenue in Generic Injectables Business (2017-2022)
11.1.5 Hospira (Pfizer Inc.) Recent Developments
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Company Details
11.2.2 Fresenius Kabi Business Overview
11.2.3 Fresenius Kabi Generic Injectables Introduction
11.2.4 Fresenius Kabi Revenue in Generic Injectables Business (2017-2022)
11.2.5 Fresenius Kabi Recent Developments
11.3 Sandoz (Novartis)
11.3.1 Sandoz (Novartis) Company Details
11.3.2 Sandoz (Novartis) Business Overview
11.3.3 Sandoz (Novartis) Generic Injectables Introduction
11.3.4 Sandoz (Novartis) Revenue in Generic Injectables Business (2017-2022)
11.3.5 Sandoz (Novartis) Recent Developments
11.4 Hikma Pharmaceuticals PLC
11.4.1 Hikma Pharmaceuticals PLC Company Details
11.4.2 Hikma Pharmaceuticals PLC Business Overview
11.4.3 Hikma Pharmaceuticals PLC Generic Injectables Introduction
11.4.4 Hikma Pharmaceuticals PLC Revenue in Generic Injectables Business (2017-2022)
11.4.5 Hikma Pharmaceuticals PLC Recent Developments
11.5 Dr. Reddy?s Laboratories Ltd
11.5.1 Dr. Reddy?s Laboratories Ltd Company Details
11.5.2 Dr. Reddy?s Laboratories Ltd Business Overview
11.5.3 Dr. Reddy?s Laboratories Ltd Generic Injectables Introduction
11.5.4 Dr. Reddy?s Laboratories Ltd Revenue in Generic Injectables Business (2017-2022)
11.5.5 Dr. Reddy?s Laboratories Ltd Recent Developments
11.6 Grifols
11.6.1 Grifols Company Details
11.6.2 Grifols Business Overview
11.6.3 Grifols Generic Injectables Introduction
11.6.4 Grifols Revenue in Generic Injectables Business (2017-2022)
11.6.5 Grifols Recent Developments
11.7 Nichi-Iko Group (Sagent)
11.7.1 Nichi-Iko Group (Sagent) Company Details
11.7.2 Nichi-Iko Group (Sagent) Business Overview
11.7.3 Nichi-Iko Group (Sagent) Generic Injectables Introduction
11.7.4 Nichi-Iko Group (Sagent) Revenue in Generic Injectables Business (2017-2022)
11.7.5 Nichi-Iko Group (Sagent) Recent Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Generic Injectables Introduction
11.8.4 Teva Pharmaceutical Revenue in Generic Injectables Business (2017-2022)
11.8.5 Teva Pharmaceutical Recent Developments
11.9 Auromedics
11.9.1 Auromedics Company Details
11.9.2 Auromedics Business Overview
11.9.3 Auromedics Generic Injectables Introduction
11.9.4 Auromedics Revenue in Generic Injectables Business (2017-2022)
11.9.5 Auromedics Recent Developments
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Generic Injectables Introduction
11.10.4 Sanofi Revenue in Generic Injectables Business (2017-2022)
11.10.5 Sanofi Recent Developments
11.11 Gland Pharma
11.11.1 Gland Pharma Company Details
11.11.2 Gland Pharma Business Overview
11.11.3 Gland Pharma Generic Injectables Introduction
11.11.4 Gland Pharma Revenue in Generic Injectables Business (2017-2022)
11.11.5 Gland Pharma Recent Developments
11.12 Endo International PLC
11.12.1 Endo International PLC Company Details
11.12.2 Endo International PLC Business Overview
11.12.3 Endo International PLC Generic Injectables Introduction
11.12.4 Endo International PLC Revenue in Generic Injectables Business (2017-2022)
11.12.5 Endo International PLC Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Generic Injectables Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Small Molecule
Table 3. Key Players of Large Molecule
Table 4. Global Generic Injectables Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Generic Injectables Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Generic Injectables Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Generic Injectables Market Share by Region (2017-2022)
Table 8. Global Generic Injectables Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Generic Injectables Market Share by Region (2023-2028)
Table 10. Generic Injectables Market Trends
Table 11. Generic Injectables Market Drivers
Table 12. Generic Injectables Market Challenges
Table 13. Generic Injectables Market Restraints
Table 14. Global Generic Injectables Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Generic Injectables Revenue Share by Players (2017-2022)
Table 16. Global Top Generic Injectables by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injectables as of 2021)
Table 17. Ranking of Global Top Generic Injectables Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Generic Injectables Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Generic Injectables Product Solution and Service
Table 21. Date of Enter into Generic Injectables Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Generic Injectables Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Generic Injectables Revenue Market Share by Type (2017-2022)
Table 25. Global Generic Injectables Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Generic Injectables Revenue Market Share by Type (2023-2028)
Table 27. Global Generic Injectables Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Generic Injectables Revenue Share by Application (2017-2022)
Table 29. Global Generic Injectables Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Generic Injectables Revenue Share by Application (2023-2028)
Table 31. North America Generic Injectables Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Generic Injectables Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Generic Injectables Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Generic Injectables Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Generic Injectables Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Generic Injectables Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Generic Injectables Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Generic Injectables Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Generic Injectables Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Generic Injectables Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Generic Injectables Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Generic Injectables Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Generic Injectables Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Generic Injectables Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Generic Injectables Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Generic Injectables Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Generic Injectables Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Generic Injectables Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Generic Injectables Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Generic Injectables Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Generic Injectables Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Generic Injectables Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Generic Injectables Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Generic Injectables Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Generic Injectables Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Generic Injectables Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Generic Injectables Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Generic Injectables Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Generic Injectables Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Generic Injectables Market Size by Country (2023-2028) & (US$ Million)
Table 61. Hospira (Pfizer Inc.) Company Details
Table 62. Hospira (Pfizer Inc.) Business Overview
Table 63. Hospira (Pfizer Inc.) Generic Injectables Product
Table 64. Hospira (Pfizer Inc.) Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
Table 65. Hospira (Pfizer Inc.) Recent Developments
Table 66. Fresenius Kabi Company Details
Table 67. Fresenius Kabi Business Overview
Table 68. Fresenius Kabi Generic Injectables Product
Table 69. Fresenius Kabi Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
Table 70. Fresenius Kabi Recent Developments
Table 71. Sandoz (Novartis) Company Details
Table 72. Sandoz (Novartis) Business Overview
Table 73. Sandoz (Novartis) Generic Injectables Product
Table 74. Sandoz (Novartis) Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
Table 75. Sandoz (Novartis) Recent Developments
Table 76. Hikma Pharmaceuticals PLC Company Details
Table 77. Hikma Pharmaceuticals PLC Business Overview
Table 78. Hikma Pharmaceuticals PLC Generic Injectables Product
Table 79. Hikma Pharmaceuticals PLC Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
Table 80. Hikma Pharmaceuticals PLC Recent Developments
Table 81. Dr. Reddy?s Laboratories Ltd Company Details
Table 82. Dr. Reddy?s Laboratories Ltd Business Overview
Table 83. Dr. Reddy?s Laboratories Ltd Generic Injectables Product
Table 84. Dr. Reddy?s Laboratories Ltd Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
Table 85. Dr. Reddy?s Laboratories Ltd Recent Developments
Table 86. Grifols Company Details
Table 87. Grifols Business Overview
Table 88. Grifols Generic Injectables Product
Table 89. Grifols Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
Table 90. Grifols Recent Developments
Table 91. Nichi-Iko Group (Sagent) Company Details
Table 92. Nichi-Iko Group (Sagent) Business Overview
Table 93. Nichi-Iko Group (Sagent) Generic Injectables Product
Table 94. Nichi-Iko Group (Sagent) Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
Table 95. Nichi-Iko Group (Sagent) Recent Developments
Table 96. Teva Pharmaceutical Company Details
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical Generic Injectables Product
Table 99. Teva Pharmaceutical Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
Table 100. Teva Pharmaceutical Recent Developments
Table 101. Auromedics Company Details
Table 102. Auromedics Business Overview
Table 103. Auromedics Generic Injectables Product
Table 104. Auromedics Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
Table 105. Auromedics Recent Developments
Table 106. Sanofi Company Details
Table 107. Sanofi Business Overview
Table 108. Sanofi Generic Injectables Product
Table 109. Sanofi Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
Table 110. Sanofi Recent Developments
Table 111. Gland Pharma Company Details
Table 112. Gland Pharma Business Overview
Table 113. Gland Pharma Generic Injectables Product
Table 114. Gland Pharma Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
Table 115. Gland Pharma Recent Developments
Table 116. Endo International PLC Company Details
Table 117. Endo International PLC Business Overview
Table 118. Endo International PLC Generic Injectables Product
Table 119. Endo International PLC Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
Table 120. Endo International PLC Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Generic Injectables Market Share by Type: 2021 VS 2028
Figure 2. Small Molecule Features
Figure 3. Large Molecule Features
Figure 4. Global Generic Injectables Market Share by Application: 2021 VS 2028
Figure 5. Oncology Case Studies
Figure 6. Anesthesia Case Studies
Figure 7. Anti-Infectives Case Studies
Figure 8. Parenteral Nutrition Case Studies
Figure 9. Cardiovascular Diseases Case Studies
Figure 10. Generic Injectables Report Years Considered
Figure 11. Global Generic Injectables Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Generic Injectables Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Generic Injectables Market Share by Region: 2021 VS 2028
Figure 14. Global Generic Injectables Market Share by Players in 2021
Figure 15. Global Top Generic Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injectables as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Generic Injectables Revenue in 2021
Figure 17. North America Generic Injectables Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Generic Injectables Market Size Market Share by Type (2017-2028)
Figure 19. North America Generic Injectables Market Size Market Share by Application (2017-2028)
Figure 20. North America Generic Injectables Market Size Share by Country (2017-2028)
Figure 21. United States Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Generic Injectables Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Generic Injectables Market Size Market Share by Type (2017-2028)
Figure 25. Europe Generic Injectables Market Size Market Share by Application (2017-2028)
Figure 26. Europe Generic Injectables Market Size Share by Country (2017-2028)
Figure 27. Germany Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Generic Injectables Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Generic Injectables Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Generic Injectables Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Generic Injectables Market Size Share by Region (2017-2028)
Figure 37. China Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Generic Injectables Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Generic Injectables Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Generic Injectables Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Generic Injectables Market Size Share by Country (2017-2028)
Figure 47. Mexico Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Generic Injectables Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Generic Injectables Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Generic Injectables Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Generic Injectables Market Size Share by Country (2017-2028)
Figure 53. Turkey Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Hospira (Pfizer Inc.) Revenue Growth Rate in Generic Injectables Business (2017-2022)
Figure 57. Fresenius Kabi Revenue Growth Rate in Generic Injectables Business (2017-2022)
Figure 58. Sandoz (Novartis) Revenue Growth Rate in Generic Injectables Business (2017-2022)
Figure 59. Hikma Pharmaceuticals PLC Revenue Growth Rate in Generic Injectables Business (2017-2022)
Figure 60. Dr. Reddy?s Laboratories Ltd Revenue Growth Rate in Generic Injectables Business (2017-2022)
Figure 61. Grifols Revenue Growth Rate in Generic Injectables Business (2017-2022)
Figure 62. Nichi-Iko Group (Sagent) Revenue Growth Rate in Generic Injectables Business (2017-2022)
Figure 63. Teva Pharmaceutical Revenue Growth Rate in Generic Injectables Business (2017-2022)
Figure 64. Auromedics Revenue Growth Rate in Generic Injectables Business (2017-2022)
Figure 65. Sanofi Revenue Growth Rate in Generic Injectables Business (2017-2022)
Figure 66. Gland Pharma Revenue Growth Rate in Generic Injectables Business (2017-2022)
Figure 67. Endo International PLC Revenue Growth Rate in Generic Injectables Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Industry Market Size
